Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
The biopharma world's manufacturing weekly
Manufacturing channel feed
European Commission seeks biopharma feedback on Novo-Catalent deal — report
5 months ago
Deals
Lonza expands bioconjugates factory; WuXi Bio adds capacity in Germany
5 months ago
Novo Nordisk to phase out its production of human insulin pens globally
5 months ago
Merck KGaA’s life science unit is still feeling the Covid demand decline
5 months ago
Pharma
Drug inspector attrition leads to 'many fewer' checks than 2016 peak, GAO says
5 months ago
FDA+
Otsuka and ICU Medical forge IV manufacturing network to supply the US
5 months ago
Deals
AstraZeneca budgets another $2B to boost manufacturing and R&D in US
5 months ago
R&D
Thermo Fisher consolidates viral vector work in Massachusetts, cuts 160 workers
5 months ago
People
FDA records request lands Chinese API manufacturer on blocked import list
6 months ago
Pharma
FDA+
Coherus restarts biosimilar supply after delays; Novavax ends Covid vaccine deal with UK
6 months ago
Avid Bioservices to be sold to private equity firms for $1.1B
6 months ago
Deals
Catalent touts customer confidence ahead of Novo deal, but misses revenue estimates
6 months ago
Nektar divests manufacturing site and reagent arm for $90M
6 months ago
Deals
Viking CEO on ‘shocking’ market reaction to oral obesity data, preparing for Phase 3
6 months ago
R&D
European Commission marks Dec. 6 for Novo-Catalent deal decision
6 months ago
Deals
Baxter pulls IV products out of China to shift supply to the US
6 months ago
China
WuXi in ‘early stages’ of CGT business review; Lonza exec becomes AGC Bio CEO
6 months ago
Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA
6 months ago
FDA+
MilliporeSigma invests €70M to triple ADC manufacturing at US site
6 months ago
WuXi AppTec is still signing on new clients despite Biosecure threat
6 months ago
China
Telix's new radiopharma spinout banks on one trial for success, CEO says
6 months ago
Startups
Post-Hoc: Novo’s obesity enemies
6 months ago
Editor's note
Pharma
GSK to spend $800M to build two vaccine factories in the US
6 months ago
Lonza extends contract with unnamed pharma; Rentschler's new build
6 months ago
First page
Previous page
4
5
6
7
8
9
10
Next page
Last page
